<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112444608</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112444608</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Communications</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Effect of a Computerized Prescribing and Calculating System on Hypo- and Hyperglycemias and on Prescribing Time Efficiency in Neonatal Intensive Care Patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Maat</surname><given-names>Barbara</given-names></name>
<degrees>PharmD</degrees>
<xref ref-type="aff" rid="aff1-0148607112444608">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rademaker</surname><given-names>Carin M. A.</given-names></name>
<degrees>PharmD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112444608">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Oostveen</surname><given-names>Marloes I.</given-names></name>
<degrees>PharmD</degrees>
<xref ref-type="aff" rid="aff2-0148607112444608">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Krediet</surname><given-names>Tannette G.</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff3-0148607112444608">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Egberts</surname><given-names>Toine C. G.</given-names></name>
<degrees>PharmD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112444608">1</xref>
<xref ref-type="aff" rid="aff2-0148607112444608">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bollen</surname><given-names>Casper W.</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-0148607112444608">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0148607112444608"><label>1</label>Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands</aff>
<aff id="aff2-0148607112444608"><label>2</label>Utrecht University, Utrecht, The Netherlands</aff>
<aff id="aff3-0148607112444608"><label>3</label>Department of Neonatology</aff>
<aff id="aff4-0148607112444608"><label>4</label>Department of Pediatric Intensive Care, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands</aff>
<author-notes>
<corresp id="corresp1-0148607112444608">B. Maat, PharmD, Department of Clinical Pharmacy, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands. Email: <email>B.Maat@umcutrecht.nl</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>37</volume>
<issue>1</issue>
<fpage>85</fpage>
<lpage>91</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>3</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p><italic>Background</italic>: Prescribing glucose requires complex calculations because glucose is present in parenteral and enteral nutrition and drug vehicles, making it error prone and contributing to the burden of prescribing errors. <italic>Objective</italic>: Evaluation of the impact of a computerized physician order entry (CPOE) system with clinical decision support (CDS) for glucose control in neonatal intensive care patients (NICU) focusing on hypo- and hyperglycemic episodes and prescribing time efficiency. <italic>Methods</italic>: An interrupted time-series design to examine the effect of CPOE on hypo- and hyperglycemias and a crossover simulation study to examine the influence of CPOE on prescribing time efficiency. NICU patients at risk for glucose imbalance hospitalized at the University Medical Center Utrecht during 2001–2007 were selected. The risks of hypo- and hyperglycemias were expressed as incidences per 100 patient days in consecutive 3-month intervals during 3 years before and after CPOE implementation. To assess prescribing time efficiency, time needed to calculate glucose intake with and without CPOE was measured. <italic>Results</italic>: No significant difference was found between pre- and post-CPOE mean incidences of hypo- and hyperglycemias per 100 hospital days of neonates at risk in every 3-month period (hypoglycemias, 4.0 [95% confidence interval, 3.2–4.8] pre-CPOE and 3.1 [2.7–3.5] post-CPOE, <italic>P</italic> = .88; hyperglycemias, 6.0 [4.3–7.7] pre-CPOE and 5.0 [3.7–6.3] post-CPOE, <italic>P</italic> = .75). CPOE led to a significant time reduction of 16% (1.3 [0.3–2.3] minutes) for simple and 60% (8.6 [5.1–12.1] minutes) for complex calculations. <italic>Conclusions</italic>: CPOE including a special CDS tool preserved accuracy for calculation and control of glucose intake and increased prescribing time efficiency.</p>
</abstract>
<kwd-group>
<kwd>glucose intake</kwd>
<kwd>neonate</kwd>
<kwd>NICU</kwd>
<kwd>computer order entry</kwd>
<kwd>CPOE</kwd>
<kwd>patient safety</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0148607112444608">
<title>Clinical Relevancy Statement</title>
<p>Prescribing glucose requires complex calculations, because glucose is present in parenteral nutrition (PN) and enteral nutrition (EN) and many drug vehicles, making it time-consuming and error prone and contributing to prescribing error rates. Information technology systems that assist in the ordering of PN and EN have been studied and may reduce these error rates. This study is the first to examine a system that calculates projected total daily glucose intake of both prescribed PN and EN and drugs in glucose-containing vehicles in neonatal intensive care patients. Introduction of this system in clinical practice preserved accuracy and improved time efficiency in prescribing PN and EN and drugs in glucose-containing vehicles.</p>
</sec>
<sec id="section2-0148607112444608" sec-type="intro">
<title>Introduction</title>
<p>Maintaining optimal glycemic control in critically ill children is difficult but important. Multiple episodes of hypoglycemia can lead to severe brain damage, whereas recurrent episodes of hyperglycemia may cause osmotic diuresis, dehydration, and weight loss. Both hypoglycemia and hyperglycemia are associated with increased mortality in critically ill children and neonates.<sup><xref ref-type="bibr" rid="bibr1-0148607112444608">1</xref><xref ref-type="bibr" rid="bibr2-0148607112444608"/><xref ref-type="bibr" rid="bibr3-0148607112444608"/><xref ref-type="bibr" rid="bibr4-0148607112444608"/><xref ref-type="bibr" rid="bibr5-0148607112444608"/><xref ref-type="bibr" rid="bibr6-0148607112444608"/><xref ref-type="bibr" rid="bibr7-0148607112444608"/><xref ref-type="bibr" rid="bibr8-0148607112444608"/>-<xref ref-type="bibr" rid="bibr9-0148607112444608">9</xref></sup></p>
<p>Accurate glucose prescribing can help achieve and maintain optimal glycemic control in critically ill children. But the prescribing process may involve complex calculations to take all variables that affect glycemia into account. The use of glucose solution as a vehicle or infusate to deliver medications, for example, is an independent risk factor in causing glycemic variability. Information technology interventions may provide support in prescribing drugs and nutrition support regimens to optimize glycemic provision, thereby reducing the incidence of errors and unintended adverse events.<sup><xref ref-type="bibr" rid="bibr10-0148607112444608">10</xref><xref ref-type="bibr" rid="bibr11-0148607112444608"/><xref ref-type="bibr" rid="bibr12-0148607112444608"/><xref ref-type="bibr" rid="bibr13-0148607112444608"/><xref ref-type="bibr" rid="bibr14-0148607112444608"/><xref ref-type="bibr" rid="bibr15-0148607112444608"/><xref ref-type="bibr" rid="bibr16-0148607112444608"/><xref ref-type="bibr" rid="bibr17-0148607112444608"/>-<xref ref-type="bibr" rid="bibr18-0148607112444608">18</xref></sup></p>
<p>Computerized physician order entry (CPOE) systems with basic clinical decision support (CDS) include drug-allergy checking, basic dosing guidance, formulary decision support, duplicate order verification, and drug-drug interaction checking.<sup><xref ref-type="bibr" rid="bibr19-0148607112444608">19</xref></sup> Systems that assist in the ordering of parenteral nutrition (PN) have been studied.<sup><xref ref-type="bibr" rid="bibr20-0148607112444608">20</xref><xref ref-type="bibr" rid="bibr21-0148607112444608"/>-<xref ref-type="bibr" rid="bibr22-0148607112444608">22</xref></sup> However, systems that combine CPOE and PN and enteral nutrition (EN) ordering by calculating the projected daily total glucose intake as a consequence of both prescriptions of drugs and PN and EN have not been described before. Such a system could facilitate the determination of the total glucose intake over a period of time.</p>
<p>In the Wilhelmina Children’s Hospital, a CPOE system with additional CDS for glucose calculations has been developed. This study evaluated the impact of CPOE with CDS as a calculation tool for glucose prescribing in a neonatal intensive care unit (NICU), focusing on hypo- and hyperglycemic episodes and prescribing time efficiency.</p>
</sec>
<sec id="section3-0148607112444608" sec-type="methods">
<title>Methods</title>
<sec id="section4-0148607112444608">
<title>Setting and Study Population</title>
<p>The study was conducted at the 28-bed level III NICU of the Wilhelmina Children’s Hospital. The Wilhelmina Children’s Hospital is part of the University Medical Center Utrecht in the Netherlands and treats an average of 540 neonates per year.</p>
<p>All neonates hospitalized for at least 1 day during 2001–2007 with 1 or more risk factors for hypo- or hyperglycemias were included. Risk factors for glucose imbalance were prematurity (&lt;37 weeks gestational age), small for gestational age (SGA; birth weight &lt;2.5th percentile for gestational age), maternal diabetes, or macrosomy (birth weight &gt;97.7th percentile for gestational age).<sup><xref ref-type="bibr" rid="bibr9-0148607112444608">9</xref>,<xref ref-type="bibr" rid="bibr23-0148607112444608">23</xref><xref ref-type="bibr" rid="bibr24-0148607112444608"/>-<xref ref-type="bibr" rid="bibr25-0148607112444608">25</xref></sup> Patients with an insulinoma were excluded. Informed consent was waived by the hospital’s medical ethics committee.</p>
<p>All included neonates were prescribed glucose (either solely or as a component of their PN). In all these neonates, plasma glucose concentrations were routinely measured to conform to local protocol (<xref ref-type="table" rid="table1-0148607112444608">Table 1</xref>). During the 6-year study period, the NICU policy concerning plasma glucose concentration measurements, cutoff points for hypo- and hyperglycemia, and associated treatment consequences remained unchanged.</p>
<table-wrap id="table1-0148607112444608" position="float">
<label>Table 1.</label>
<caption>
<p>Neonatal Intensive Care Unit Glucose Policy.</p>
</caption>
<graphic alternate-form-of="table1-0148607112444608" xlink:href="10.1177_0148607112444608-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="3">Plasma glucose concentrations</th>
</tr>
</thead>
<tbody>
<tr>
<td> Normal plasma glucose concentration</td>
<td>2.6–7.0 mmol/L</td>
<td>47–126 mg/dL</td>
</tr>
<tr>
<td> Hypoglycemia</td>
<td>&lt;2.5 mmol/L</td>
<td>&lt;45 mg/dL</td>
</tr>
<tr>
<td> Hyperglycemia</td>
<td>&gt;10 mmol/L</td>
<td>&gt;180 mg/dL</td>
</tr>
<tr>
<td colspan="3">Glucose intake</td>
</tr>
<tr>
<td> Minimal glucose intake</td>
<td colspan="2">4–6 mg/kg/min</td>
</tr>
<tr>
<td colspan="3">Plasma glucose concentration measurements</td>
</tr>
<tr>
<td colspan="3"> Enteral nutrition: neonate with enteral feeding within 3 hours after birth: plasma glucose concentration measurement 1 and 2 hours after birth and before first feeding, subsequently at least twice a day until plasma glucose concentration is stable and normal</td>
</tr>
<tr>
<td colspan="3"> Parenteral nutrition: neonate with parenteral glucose: plasma glucose concentration measurement before starting intravenous glucose, subsequently every 3–4 hours and then at least once a day</td>
</tr>
<tr>
<td colspan="3">Hypoglycemia</td>
</tr>
<tr>
<td colspan="3"> Plasma glucose concentration &lt;2.5 mmol/L (&lt;45 mg/dL): adjustment of glucose intake</td>
</tr>
<tr>
<td colspan="3"> Symptomatic hypoglycemia: slow (in 5–10 minutes) injection of 0.2 g glucose/kg (2 mL glucose 10%/kg) intravenously</td>
</tr>
<tr>
<td colspan="3">Hyperglycemia</td>
</tr>
<tr>
<td colspan="3"> Plasma glucose concentration &gt;10 mmol/L (&gt;180 mg/dL): adjustment of glucose concentration</td>
</tr>
<tr>
<td colspan="3"> In exceptional cases, continuous intravenous insulin infusion (0.01 IU/kg/h, max 0.1 IU/kg/h, titrated to plasma glucose concentrations)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section5-0148607112444608">
<title>Design</title>
<p>Hypo- and hyperglycemic episodes were used as a measure for the accuracy of daily total glucose intake prescribing. An interrupted time-series (ITS) design was used to examine the effect of CPOE on these hypo- and hyperglycemic episodes.<sup><xref ref-type="bibr" rid="bibr26-0148607112444608">26</xref>,<xref ref-type="bibr" rid="bibr27-0148607112444608">27</xref></sup> A simulation study was performed to examine the influence of CPOE on prescribing time. Prescribing time was defined as the time (in minutes) needed to calculate glucose intake for NICU patients, taking both nutrition and medication into account. To determine the time that prescribers needed to calculate glucose intake, 7 randomly selected neonatologists, fellows, and residents were asked to calculate glucose intake (mg/kg/min) for 3 different clinical scenarios similar to real-life situations, both manually and with CPOE, in a crossover design. The 3 simulation cases are described in <xref ref-type="table" rid="table2-0148607112444608">Table 2</xref>. Differences in calculation times between the different levels of prescribers were not studied.</p>
<table-wrap id="table2-0148607112444608" position="float">
<label>Table 2.</label>
<caption>
<p>Description of the 3 Simulation Cases.</p>
</caption>
<graphic alternate-form-of="table2-0148607112444608" xlink:href="10.1177_0148607112444608-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
</colgroup>
<tbody>
<tr>
<td><italic>Case 1</italic></td>
</tr>
<tr>
<td>3000 g, 40 weeks old, born March 5, 2008. Solely IV nutrition: PN, glucose intake 7.3 mg/kg/min. Plasma glucose concentration is a bit low (eg, 2.5 mmol/l), so 1 mg/kg/min should be added to the parenteral glucose intake. Calculate how to compose a PN infusion, needed for a higher glucose intake (1 mg/kg/min higher)</td>
</tr>
<tr>
<td><italic>Case 2</italic></td>
</tr>
<tr>
<td>1500 g, 32 weeks old. Total enteral nutrition (“Friso Premature” baby food, 8 g of carbohydrates per 100 mL): 10 mL, 24 times a day. Collapses because of neonatal necrotizing enterocolitis. Has to be put on PN (nil per os). Neonate is mechanically ventilated, for which morphine is given (about 0.25 mg/kg/d in glucose 10% IV). Neonate tends to have hypotension, for which it receives dopamine (about 5 µg/kg/min in glucose 10% IV). Has an arterial line. Calculate how to compose a PN infusion (160 mL/kg/d), needed for a lower glucose intake (2 mg/kg/min lower) because of hyperglycemia.</td>
</tr>
<tr>
<td><italic>Case 3</italic></td>
</tr>
<tr>
<td>Neonate 27 weeks, 650 g. Step-up enteral feeding. Received breast milk: 2 mL, 24 times a day. Now receives breast milk: 3 mL, 24 times a day. Calculate the glucose intake of the former and latter regimen. Breast milk: 7 g of carbohydrate per 100 mL.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0148607112444608">
<p>IV, intravenous; PN, parenteral nutrition.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section6-0148607112444608">
<title>Intervention</title>
<p>On April 26, 2004, a homegrown CPOE system was introduced, designed to perform physician order entry and basic CDS. Also, it provides calculations to assist prescribing of glucose, taking the amount of glucose present in PN and EN and medication into account. The CPOE system interfaces with hospital-wide systems, for example, with regard to laboratory test results. An additional connection between the CPOE system and the hospital’s PN compounding pump has not been realized yet.</p>
<p>Before CPOE implementation, glucose intake was manually calculated on a paper order sheet. The interface of the CPOE system (<xref ref-type="fig" rid="fig1-0148607112444608">Figure 1</xref>) was designed to look similar to this sheet to enhance acceptance of the system.</p>
<fig id="fig1-0148607112444608" position="float">
<label>Figure 1.</label>
<caption>
<p>Interface of the computerized physician order entry system: total intake, patient characteristics, enteral nutrition, parenteral nutrition, and intravenous medication.</p>
</caption>
<graphic xlink:href="10.1177_0148607112444608-fig1.tif"/>
</fig>
</sec>
<sec id="section7-0148607112444608">
<title>Outcomes</title>
<p>The primary outcomes were the pre- and post-CPOE incidences of hypo- and hyperglycemic episodes of patients at risk. Hypo- and hyperglycemic episodes were defined as plasma glucose concentrations &lt;2.5 mmol/L and &gt;10 mmol/L (or &lt;45 mg/dL and &gt;180 mg/dL), respectively, in accordance with the local NICU glucose policy (<xref ref-type="table" rid="table1-0148607112444608">Table 1</xref>).</p>
<p>Also, the general pre-CPOE fluctuation of plasma glucose concentrations of patients at risk was compared with the general post-CPOE fluctuation. The 6-year study period was divided into consecutive 3-month intervals, resulting in 12 pre- and 12 post-CPOE intervals.</p>
<p>To adjust for the length of stay of the patients, the incidences of hypo- and hyperglycemic episodes <italic>per 100 hospital days</italic> of patients at risk were determined for each 3-month period. To adjust for differences in the frequency of glucose checks per neonate in our population, the numbers of hypo- and hyperglycemias <italic>per 100 glucose measurements</italic> of patients at risk were also established for each 3-month period.</p>
<p>Outcome for prescribing time efficiency was the prescribing time: the time (in minutes, rounded up) needed to calculate glucose intake with and without the use of CPOE. A significant decrease in prescribing time was considered an increase in prescribing time efficiency.</p>
</sec>
<sec id="section8-0148607112444608">
<title>Data Collection</title>
<p>Patient characteristics, such as birth weight, gender, gestational age (weeks), and diagnoses, were selected from the Nationwide Neonatal Registry system, a nationwide database where all neonates in the Netherlands are registered.</p>
<p>Glucose measurement results were extracted from the Utrecht Patient Oriented Database (UPOD) in which routine clinical laboratory results are linked to administrative data (eg, patient characteristics) and clinical data (eg, medication, diagnoses, procedures).<sup><xref ref-type="bibr" rid="bibr28-0148607112444608">28</xref></sup> Plasma glucose concentrations were determined at least once daily; samples were taken from an arterial catheter and measured in the hospital’s central lab. During the 6-year study period, the NICU policy concerning plasma glucose concentration measurements remained unchanged (<xref ref-type="table" rid="table1-0148607112444608">Table 1</xref>).</p>
</sec>
<sec id="section9-0148607112444608">
<title>Statistical Analysis</title>
<p>A χ<sup>2</sup> analysis and unpaired Student <italic>t</italic> test were used to compare the pre-CPOE and post-CPOE patient groups (α = 0.05). Regression analysis, with inverse variance-weighted ratios per 3-month period, was used to estimate and compare trends of numbers of hyper- and hypoglycemias pre- and post-CPOE implementation. To assess whether CPOE implementation had a different effect in SGAs than in neonates appropriate for gestational age, a stratified analysis was performed as well. To compare the fluctuation of plasma glucose concentrations of patients at risk pre- and post-CPOE, median and mean plasma glucose concentrations were calculated. SPSS Version 15.0.1 for Windows (SPSS, Inc, an IBM Company, Chicago, Illinois) was used for all analyses.</p>
<p>The study design met the generally recommended criteria for an ITS study—that is, among others, at least 3 data points before and 3 data points after the intervention—to conduct regression analysis and protect against secular variation.<sup><xref ref-type="bibr" rid="bibr27-0148607112444608">27</xref>,<xref ref-type="bibr" rid="bibr29-0148607112444608">29</xref></sup> The desirable number of at least 100 observations per data point to achieve an acceptable level of variability of the estimate at each time point was also achieved.<sup><xref ref-type="bibr" rid="bibr27-0148607112444608">27</xref>,<xref ref-type="bibr" rid="bibr29-0148607112444608">29</xref></sup></p>
</sec>
</sec>
<sec id="section10-0148607112444608" sec-type="results">
<title>Results</title>
<sec id="section11-0148607112444608">
<title>Patients</title>
<p>This study included 2040 patients (<xref ref-type="table" rid="table3-0148607112444608">Table 3</xref>). Mean (SD) birth weight was significantly lower before CPOE implementation (1659 [769] g pre-CPOE vs 1735 [823] g post-CPOE, <italic>P</italic> = .03). Concurrently, the mean number of SGAs was significantly higher before CPOE implementation (102 pre-CPOE vs 57 post-CPOE, <italic>P</italic> &lt; .01).</p>
<table-wrap id="table3-0148607112444608" position="float">
<label>Table 3.</label>
<caption>
<p>Comparison of Patient Characteristics Before and After Computerized Physician Order Entry (CPOE) System Implementation.</p>
</caption>
<graphic alternate-form-of="table3-0148607112444608" xlink:href="10.1177_0148607112444608-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Pre-CPOE<sup><xref ref-type="table-fn" rid="table-fn2-0148607112444608">a</xref></sup> (n = 1070)</th>
<th align="center">Post-CPOE<sup><xref ref-type="table-fn" rid="table-fn2-0148607112444608">a</xref></sup> (n = 970)</th>
<th align="center"><italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Male, No. (%)</td>
<td>608 (56.8)</td>
<td>566 (58.4)</td>
<td>.49</td>
</tr>
<tr>
<td>Length of admission, d, mean (SD)</td>
<td>19.4 (20.1)</td>
<td>20.4 (22.5)</td>
<td>.31</td>
</tr>
<tr>
<td>Weeks of pregnancy, mean (SD)</td>
<td>31.8 (3.3)</td>
<td>31.9 (3.4)</td>
<td>.36</td>
</tr>
<tr>
<td>Grams birth weight, mean (SD)</td>
<td>1659 (769)</td>
<td>1735 (823)</td>
<td>.03</td>
</tr>
<tr>
<td>Premature infants,<sup><xref ref-type="table-fn" rid="table-fn3-0148607112444608">b</xref></sup> No. (%)</td>
<td>1010 (94.4)</td>
<td>905 (93.3)</td>
<td>.30</td>
</tr>
<tr>
<td>SGA,<sup><xref ref-type="table-fn" rid="table-fn4-0148607112444608">c</xref></sup> No. (%)</td>
<td>102 (9.5)</td>
<td>57 (5.9)</td>
<td>&lt;.01</td>
</tr>
<tr>
<td>Maternal diabetes, No. (%)</td>
<td>51 (4.8)</td>
<td>50 (5.1)</td>
<td>.69</td>
</tr>
<tr>
<td>Macrosomy,<sup><xref ref-type="table-fn" rid="table-fn5-0148607112444608">d</xref></sup> No. (%)</td>
<td>28 (2.6)</td>
<td>37 (3.8)</td>
<td>.12</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0148607112444608">
<label>a</label>
<p>Pre-CPOE: April 2001–March 2004 (3 years); post-CPOE: April 2004–March 2007 (3 years).</p>
</fn>
<fn id="table-fn3-0148607112444608">
<label>b</label>
<p>Premature infants: &lt;37 weeks of gestational age.</p>
</fn>
<fn id="table-fn4-0148607112444608">
<label>c</label>
<p>SGA, small for gestational age: birth weight &lt;2.5th percentile for gestational age.</p>
</fn>
<fn id="table-fn5-0148607112444608">
<label>d</label>
<p>Macrosomy: birth weight &gt;97.7th percentile for gestational age.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section12-0148607112444608">
<title>Effect of CPOE on Hypo- and Hyperglycemias</title>
<p>There was no significant difference between the pre- and post-CPOE mean numbers of hypo- and hyperglycemias per 100 hospital days of patients at risk in every 3-month period (hypoglycemias, 4.0 [95% confidence interval (CI), 3.2–4.8] pre-CPOE and 3.1 [2.7–3.5] post-CPOE, <italic>P</italic> = .88; hyperglycemias, 6.0 [4.3–7.7] pre-CPOE and 5.0 [3.7–6.3] post-CPOE, <italic>P</italic> = .75) (<xref ref-type="fig" rid="fig2-0148607112444608">Figure 2</xref>).</p>
<fig id="fig2-0148607112444608" position="float">
<label>Figure 2.</label>
<caption>
<p>Number of hypo- and hyperglycemias per 100 hospital days of patients at risk in every 3-month period. CPOE, computerized physician order entry.</p>
</caption>
<graphic xlink:href="10.1177_0148607112444608-fig2.tif"/>
</fig>
<p>Stratification for SGA showed no effect: hypo- and hyperglycemia incidences per 100 hospital days of patients at risk in every 3-month period in SGAs were 6.3 (95% CI, 3.9–8.7) and 9.6 (5.5–13.7) pre-CPOE vs 6.9 (4.6–9.2) and 7.6 (2.6– 12.6) post-CPOE. Hypo- and hyperglycemia incidences per 100 hospital days of patients at risk in every 3-month period in neonates appropriate for gestational age were 3.7 (95% CI, 2.9–4.5) and 5.5 (3.9–7.1) pre-CPOE vs 2.9 (2.5–3.4) and 5.1 (3.7–6.5) post-CPOE.</p>
<p>There was no significant difference between the pre- and post-CPOE mean numbers of hypo- and hyperglycemias per 100 glucose measurements of patients at risk in every 3-month period (hypoglycemias, 2.1 [95% CI, 1.7–2.5] pre-CPOE and 1.7 [1.4–2.0] post-CPOE, <italic>P</italic> = .91; hyperglycemias, 3.1 [2.4–3.8] pre-CPOE and 2.6 [1.9–3.3] post-CPOE, <italic>P</italic> = .74).</p>
<p>There was no difference in the fluctuation of plasma glucose concentrations of patients at risk pre- and post-CPOE: pre-CPOE, the median plasma glucose concentration was 4.8 (interquartile range [IQR], 4.0–5.8) mmol/L, and the mean (SD) plasma glucose concentration was 5.2 (0.01) mmol/L. Post-CPOE, the median plasma glucose concentration was 4.7 (IQR, 4.0–5.6) mmol/L, and the mean (SD) plasma glucose concentration was 5.0 (0.01) mmol/L.</p>
</sec>
<sec id="section13-0148607112444608">
<title>Efficiency</title>
<p>All physicians completed the simulation cases correctly, both manually and with CPOE (<xref ref-type="fig" rid="fig3-0148607112444608">Figure 3</xref>). Comparing CPOE with manual calculation showed a significant time reduction of 1.3 (95% CI, 0.3–2.3) minutes (16%) for simple and 8.6 (5.1–12.1) minutes (60%) for complex cases.</p>
<fig id="fig3-0148607112444608" position="float">
<label>Figure 3.</label>
<caption>
<p>Time needed to calculate simulation cases 1, 2, and 3 per physicians 1–7 (in minutes), both manually and with the computerized physician order entry (CPOE) system.</p>
</caption>
<graphic xlink:href="10.1177_0148607112444608-fig3.tif"/>
</fig>
</sec>
</sec>
<sec id="section14-0148607112444608" sec-type="discussion">
<title>Discussion</title>
<sec id="section15-0148607112444608">
<title>Principal Findings</title>
<p>This study demonstrates that after implementation of a CPOE system in the NICU, a high level of accuracy for calculation and control of glucose intake was maintained. There was no difference between the incidences of hypo- and hyperglycemias per hospital day or in the fluctuation of plasma glucose concentrations of patients at risk before and after CPOE/CDS implementation. However, comparing CPOE with manual calculation did show a significant time reduction, particularly for complex calculations.</p>
</sec>
<sec id="section16-0148607112444608">
<title>Implications</title>
<p>The results indicate that prescription of glucose intake was accurate both with CPOE and with manual calculation. It is expected that the time-saving impact positively affects the quality of patient care, as more time can be spent at the bedside. Conversely, Han et al<sup><xref ref-type="bibr" rid="bibr30-0148607112444608">30</xref></sup> found that with CPOE, more time was spent at the computer and less at the bedside, which resulted in a higher mortality after CPOE implementation. However, a recent systematic review on the effect of CPOE on medication prescription errors and clinical outcome in intensive care unit (ICU) settings showed that mortality was generally not influenced.<sup><xref ref-type="bibr" rid="bibr31-0148607112444608">31</xref></sup> A recent ITS study also showed similar results: a CPOE system with basic CDS reduced the incidence of medication errors but did not affect actual patient harm (measured as preventable adverse drug events) in an inpatient population.<sup><xref ref-type="bibr" rid="bibr32-0148607112444608">32</xref></sup> In neonates specifically, Kazemi et al<sup><xref ref-type="bibr" rid="bibr33-0148607112444608">33</xref></sup> studied the effect of CPOE and CDS with a medication dosing calculation tool and noted a significant reduction in dosing errors. None of these studies, though, focused on a specific CDS item for calculation and control of glucose intake via both PN and EN and medication. In adult and pediatric ICU settings, electronical support of glucose control has been studied before, but focusing on insulin treatment protocols, not on glucose intake.<sup><xref ref-type="bibr" rid="bibr34-0148607112444608">34</xref><xref ref-type="bibr" rid="bibr35-0148607112444608"/><xref ref-type="bibr" rid="bibr36-0148607112444608"/><xref ref-type="bibr" rid="bibr37-0148607112444608"/><xref ref-type="bibr" rid="bibr38-0148607112444608"/><xref ref-type="bibr" rid="bibr39-0148607112444608"/><xref ref-type="bibr" rid="bibr40-0148607112444608"/>-<xref ref-type="bibr" rid="bibr41-0148607112444608">41</xref></sup></p>
</sec>
<sec id="section17-0148607112444608">
<title>Comparison to Other Studies</title>
<p>To our knowledge, this is the first evaluation of the effects of a CPOE system, including calculations to assist prescribing of glucose, on glycemic control in an NICU population. The rates of glucose imbalance in the study population were comparable to rates found in other studies among infants with 1 or more risk factors for glucose imbalance. This study found at least 1 episode of hypoglycemia in 32% and hyperglycemia in 27% of neonatal patients, consistent with the percentages others found: an incidence of hypo- and hyperglycemias of 35% and 24%, respectively, although slightly different definitions were used in their studies (&lt;2.2 mmol/L and &gt;12 mmol/L, respectively).<sup><xref ref-type="bibr" rid="bibr9-0148607112444608">9</xref>,<xref ref-type="bibr" rid="bibr42-0148607112444608">42</xref></sup></p>
</sec>
<sec id="section18-0148607112444608">
<title>Limitations</title>
<p>Potential confounding in ITS studies is limited to factors that are related to the outcome, and that changed at the time of the intervention, such as cointerventions, seasonal changes, changes in measurement of the outcome, and changes of the study population during the time of intervention.<sup><xref ref-type="bibr" rid="bibr27-0148607112444608">27</xref></sup> As mentioned before, this study’s time span was long enough to rule out seasonal changes, and NICU policy concerning plasma glucose concentration measurements, cutoff points for hypo- and hyperglycemia, and associated treatment consequences remained unchanged. One limitation that may have affected the results is the lower mean body weight in the pre-CPOE population. This may be due to the higher number of SGAs in the pre-CPOE population. Stratifying for SGA, though, showed similar results. Another limitation of this study is that comparing the studied CPOE system with others may be complicated as the system was developed locally and is used in the pediatric ICU and NICU of the Wilhelmina Children’s Hospital only. Nonetheless, as recently described by Caldwell et al,<sup><xref ref-type="bibr" rid="bibr43-0148607112444608">43</xref></sup> this kind of research is required for evidence-based development and optimization of CPOE systems and CDS tools. Commercially available CPOE systems are currently not tailored to pediatrics and do not necessarily improve error rates and clinical effectiveness of pediatric prescribing.<sup><xref ref-type="bibr" rid="bibr43-0148607112444608">43</xref></sup> Accordingly, CPOE systems need further evolution by the development of CDS specific for pediatric and neonatal settings. The calculation tool for glucose prescribing in this study is an example of such a development.</p>
</sec>
</sec>
<sec id="section19-0148607112444608" sec-type="conclusions">
<title>Conclusions</title>
<p>In conclusion, the introduction of a basic CPOE system that provides support for complex calculations preserved the accuracy and improved the efficiency in prescribing glucose intake in NICU patients. Future studies, preferably multicenter and designed as controlled before/after studies, are warranted to elucidate the role of CPOE in the improvement of patient care and safety in neonatal and pediatric intensive care settings.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112444608">
<label>1.</label>
<citation citation-type="journal">
<collab>NICE-SUGAR Study Investigators</collab>, <person-group person-group-type="author">
<name><surname>Finfer</surname><given-names>S</given-names></name>
<name><surname>Chittok</surname><given-names>DR</given-names></name>
<etal/>
</person-group>. <article-title>Intensive versus conventional glucose control in critically ill patients</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>:<fpage>1283</fpage>-<lpage>1297</lpage>.</citation>
</ref>
<ref id="bibr2-0148607112444608">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vlasselaers</surname><given-names>D</given-names></name>
<name><surname>Milants</surname><given-names>I</given-names></name>
<name><surname>Desmet</surname><given-names>L</given-names></name><etal/>
</person-group>. <article-title>Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised, controlled study</article-title>. <source>Lancet</source>. <year>2009</year>;<volume>373</volume>:<fpage>547</fpage>-<lpage>556</lpage>.</citation>
</ref> <ref id="bibr3-0148607112444608">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ulate</surname><given-names>KP.</given-names></name>
</person-group> <article-title>A critical appraisal of Vlasselaers D, Milants I, Desmet L, et al: intensive insulin therapy for patients in paediatric intensive care: a prospective, randomized controlled study</article-title>. <source>Lancet</source> <year>2009</year>;<volume>373</volume>:<fpage>547</fpage>-<lpage>556</lpage>. <source>Pediatr Crit Care Med</source>. <year>2011</year>;<volume>12</volume>:<fpage>455</fpage>-<lpage>458</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112444608">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rake</surname><given-names>AJ</given-names></name>
<name><surname>Srinivasan</surname><given-names>V</given-names></name>
<name><surname>Nadkarni</surname><given-names>V</given-names></name>
<name><surname>Kaptan</surname><given-names>R</given-names></name>
<name><surname>Newth</surname><given-names>CJ.</given-names></name>
</person-group> <article-title>Glucose variability and survival in critically ill children: allostasis or harm?</article-title> <source>Pediatr Crit Care Med</source>. <year>2010</year>;<volume>11</volume>:<fpage>707</fpage>-<lpage>712</lpage>.</citation>
</ref>
<ref id="bibr5-0148607112444608">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Faustino</surname><given-names>EV</given-names></name>
<name><surname>Bogue</surname><given-names>CW.</given-names></name>
</person-group> <article-title>Relationship between hypoglycemia and mortality in critically ill children</article-title>. <source>Pediatr Crit Care Med</source>. <year>2010</year>;<volume>11</volume>:<fpage>690</fpage>-<lpage>698</lpage>.</citation>
</ref>
<ref id="bibr6-0148607112444608">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yung</surname><given-names>M</given-names></name>
<name><surname>Wilkins</surname><given-names>B</given-names></name>
<name><surname>Norton</surname><given-names>L</given-names></name>
<name><surname>Slater</surname><given-names>A</given-names></name>
</person-group>; <collab>Paediatric Study Group; Australian and New Zealand Intensive Care Society</collab>. <article-title>Glucose control, organ failure, and mortality in pediatric intensive care</article-title>. <source>Pediatr Crit Care Med</source>. <year>2008</year>;<volume>9</volume>:<fpage>147</fpage>-<lpage>152</lpage>.</citation>
</ref>
<ref id="bibr7-0148607112444608">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wintergerst</surname><given-names>KA</given-names></name>
<name><surname>Buckingham</surname><given-names>B</given-names></name>
<name><surname>Gandrud</surname><given-names>L</given-names></name>
<name><surname>Wong</surname><given-names>BJ</given-names></name>
<name><surname>Kache</surname><given-names>S</given-names></name>
<name><surname>Wilson</surname><given-names>DM.</given-names></name>
</person-group> <article-title>Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit</article-title>. <source>Pediatrics</source>. <year>2006</year>;<volume>118</volume>:<fpage>173</fpage>-<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr8-0148607112444608">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hume</surname><given-names>R</given-names></name>
<name><surname>Burchell</surname><given-names>A</given-names></name>
<name><surname>Williams</surname><given-names>FL</given-names></name>
<name><surname>Koh</surname><given-names>DK.</given-names></name>
</person-group> <article-title>Glucose homeostasis in the newborn</article-title>. <source>Early Hum Dev</source>. <year>2005</year>;<volume>81</volume>:<fpage>95</fpage>-<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr9-0148607112444608">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zanardo</surname><given-names>V</given-names></name>
<name><surname>Cagdas</surname><given-names>S</given-names></name>
<name><surname>Golin</surname><given-names>R</given-names></name>
<name><surname>Trevisanuto</surname><given-names>D</given-names></name>
<name><surname>Marzari</surname><given-names>F</given-names></name>
<name><surname>Rizzo</surname><given-names>L.</given-names></name>
</person-group> <article-title>Risk factors of hypoglycemia in premature infants</article-title>. <source>Fetal Diagn Ther</source>. <year>1999</year>;<volume>14</volume>:<fpage>63</fpage>-<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr10-0148607112444608">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bankhead</surname><given-names>R</given-names></name>
<name><surname>Boullata</surname><given-names>J</given-names></name>
<name><surname>Brantley</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Enteral nutrition practice recommendations</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2009</year>;<volume>33</volume>:<fpage>122</fpage>-<lpage>167</lpage>.</citation>
</ref>
<ref id="bibr11-0148607112444608">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taylor</surname><given-names>JA</given-names></name>
<name><surname>Loan</surname><given-names>LA</given-names></name>
<name><surname>Kamara</surname><given-names>J</given-names></name>
<name><surname>Blackburn</surname><given-names>S</given-names></name>
<name><surname>Whitney</surname><given-names>D.</given-names></name>
</person-group> <article-title>Medication administration variances before and after implementation of computerized physician order entry in a neonatal intensive care unit</article-title>. <source>Pediatrics</source>. <year>2008</year>;<volume>121</volume>:<fpage>123</fpage>-<lpage>128</lpage>.</citation>
</ref>
<ref id="bibr12-0148607112444608">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walsh</surname><given-names>KE</given-names></name>
<name><surname>Landrigan</surname><given-names>CP</given-names></name>
<name><surname>Adams</surname><given-names>WG</given-names></name><etal/>
</person-group>. <article-title>Effect of computer order entry on prevention of serious medication errors in hospitalized children</article-title>. <source>Pediatrics</source>. <year>2008</year>;<volume>121</volume>:<fpage>e421</fpage>-<lpage>e427</lpage>.</citation>
</ref>
<ref id="bibr13-0148607112444608">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chedoe</surname><given-names>I</given-names></name>
<name><surname>Molendijk</surname><given-names>HA</given-names></name>
<name><surname>Dittrich</surname><given-names>ST</given-names></name><etal/>
</person-group>. <article-title>Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety: a review of the current literature</article-title>. <source>Drug Saf</source>. <year>2007</year>;<volume>30</volume>:<fpage>503</fpage>-<lpage>513</lpage>.</citation>
</ref>
<ref id="bibr14-0148607112444608">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Larsen</surname><given-names>GY</given-names></name>
<name><surname>Parker</surname><given-names>HB</given-names></name>
<name><surname>Cash</surname><given-names>J</given-names></name>
<name><surname>O’Connell</surname><given-names>M</given-names></name>
<name><surname>Grant</surname><given-names>MC.</given-names></name>
</person-group> <article-title>Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients</article-title>. <source>Pediatrics</source>. <year>2005</year>;<volume>116</volume>:<fpage>e21</fpage>-<lpage>e25</lpage>.</citation>
</ref>
<ref id="bibr15-0148607112444608">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Seres</surname><given-names>D</given-names></name>
<name><surname>Sacks</surname><given-names>GS</given-names></name>
<name><surname>Pedersen</surname><given-names>CA</given-names></name><etal/>
</person-group>. <article-title>Parenteral nutrition safe practices: results of the 2003 American Society for Parenteral and Enteral Nutrition survey</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2006</year>;<volume>30</volume>:<fpage>259</fpage>-<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr16-0148607112444608">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mirtallo</surname><given-names>J</given-names></name>
<name><surname>Canada</surname><given-names>T</given-names></name>
<name><surname>Johnson</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Safe practices for parenteral nutrition</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2004</year>;<volume>28</volume>:<fpage>S39</fpage>-<lpage>S70</lpage>.</citation>
</ref>
<ref id="bibr17-0148607112444608">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaushal</surname><given-names>R</given-names></name>
<name><surname>Bates</surname><given-names>DW</given-names></name>
<name><surname>Landrigan</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Medication errors and adverse drug events in pediatric inpatients</article-title>. <source>JAMA</source>. <year>2001</year>;<volume>285</volume>:<fpage>2114</fpage>-<lpage>2120</lpage>.</citation>
</ref>
<ref id="bibr18-0148607112444608">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaushal</surname><given-names>R</given-names></name>
<name><surname>Barker</surname><given-names>KN</given-names></name>
<name><surname>Bates</surname><given-names>DW.</given-names></name>
</person-group> <article-title>How can information technology improve patient safety and reduce medication errors in children’s health care?</article-title> <source>Arch Pediatr Adolesc Med</source>. <year>2001</year>;<volume>155</volume>:<fpage>1002</fpage>-<lpage>1007</lpage>.</citation>
</ref>
<ref id="bibr19-0148607112444608">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuperman</surname><given-names>GJ</given-names></name>
<name><surname>Bobb</surname><given-names>A</given-names></name>
<name><surname>Payne</surname><given-names>TH</given-names></name><etal/>
</person-group>. <article-title>Medication-related clinical decision support in computerized provider order entry systems: a review</article-title>. <source>J Am Med Inform Assoc</source>. <year>2007</year>;<volume>14</volume>:<fpage>29</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr20-0148607112444608">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lehmann</surname><given-names>CU</given-names></name>
<name><surname>Conner</surname><given-names>KG</given-names></name>
<name><surname>Cox</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Provider error prevention: online total parenteral nutrition calculator</article-title>. <source>Proc AMAI Symp</source>. <volume>2002</volume>:<fpage>435</fpage>-<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr21-0148607112444608">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lehmann</surname><given-names>CU</given-names></name>
<name><surname>Conner</surname><given-names>KG</given-names></name>
<name><surname>Cox</surname><given-names>JM.</given-names></name>
</person-group> <article-title>Preventing provider errors: online total parenteral nutrition calculator</article-title>. <source>Pediatrics</source>. <year>2004</year>;<volume>113</volume>:<fpage>748</fpage>-<lpage>753</lpage>.</citation>
</ref>
<ref id="bibr22-0148607112444608">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lehmann</surname><given-names>CU</given-names></name>
<name><surname>Kim</surname><given-names>GR</given-names></name>
<name><surname>Gujral</surname><given-names>R</given-names></name>
<name><surname>Veltri</surname><given-names>MA</given-names></name>
<name><surname>Clark</surname><given-names>JS</given-names></name>
<name><surname>Miller</surname><given-names>MR.</given-names></name>
</person-group> <article-title>Decreasing errors in pediatric continuous intravenous infusions</article-title>. <source>Pediatr Crit Care Med</source>. <year>2006</year>;<volume>7</volume>:<fpage>225</fpage>-<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr23-0148607112444608">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferrara</surname><given-names>A</given-names></name>
<name><surname>Weiss</surname><given-names>NS</given-names></name>
<name><surname>Hedderson</surname><given-names>MM</given-names></name><etal/>
</person-group>. <article-title>Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia</article-title>. <source>Diabetologia</source>. <year>2007</year>;<volume>50</volume>:<fpage>298</fpage>-<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr24-0148607112444608">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kao</surname><given-names>LS</given-names></name>
<name><surname>Morris</surname><given-names>BH</given-names></name>
<name><surname>Lally</surname><given-names>KP</given-names></name>
<name><surname>Stewart</surname><given-names>CD</given-names></name>
<name><surname>Huseby</surname><given-names>V</given-names></name>
<name><surname>Kennedy</surname><given-names>KA.</given-names></name>
</person-group> <article-title>Hyperglycemia and morbidity and mortality in extremely low birth weight infants</article-title>. <source>J Perinatol</source>. <year>2006</year>;<volume>26</volume>:<fpage>730</fpage>-<lpage>736</lpage>.</citation>
</ref>
<ref id="bibr25-0148607112444608">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hey</surname><given-names>E.</given-names></name>
</person-group> <article-title>Hyperglycaemia and the very preterm baby</article-title>. <source>Semin Fetal Neonatal Med</source>. <year>2005</year>;<volume>10</volume>:<fpage>377</fpage>-<lpage>387</lpage>.</citation>
</ref>
<ref id="bibr26-0148607112444608">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mol</surname><given-names>PG</given-names></name>
<name><surname>Wieringa</surname><given-names>JE</given-names></name>
<name><surname>Nannanpanday</surname><given-names>PV</given-names></name><etal/>
</person-group>. <article-title>Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis</article-title>. <source>J Antimicrob Chemother</source>. <year>2005</year>;<volume>55</volume>:<fpage>550</fpage>-<lpage>557</lpage>.</citation>
</ref>
<ref id="bibr27-0148607112444608">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wagner</surname><given-names>AK</given-names></name>
<name><surname>Soumerai</surname><given-names>SB</given-names></name>
<name><surname>Zhang</surname><given-names>F</given-names></name>
<name><surname>Ross-Degnan</surname><given-names>D.</given-names></name>
</person-group> <article-title>Segmented regression analysis of interrupted time series studies in medication use research</article-title>. <source>J Clin Pharm Ther</source>. <year>2002</year>;<volume>27</volume>:<fpage>299</fpage>-<lpage>309</lpage>.</citation>
</ref>
<ref id="bibr28-0148607112444608">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>ten Berg</surname><given-names>MJ</given-names></name>
<name><surname>Huisman</surname><given-names>A</given-names></name>
<name><surname>van den Bemt</surname><given-names>PM</given-names></name>
<name><surname>Schobben</surname><given-names>AF</given-names></name>
<name><surname>Egberts</surname><given-names>AC</given-names></name>
<name><surname>van Solinge</surname><given-names>WW.</given-names></name>
</person-group> <article-title>Linking laboratory and medication data: new opportunities for pharmacoepidemiological research</article-title>. <source>Clin Chem Lab Med</source>. <year>2007</year>;<volume>45</volume>:<fpage>13</fpage>-<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr29-0148607112444608">
<label>29.</label>
<citation citation-type="web">
<collab>The Cochrane Effective Practice and Organisation of Care Group (EPOC)</collab>. <ext-link ext-link-type="uri" xlink:href="http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/inttime.pdf">http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/inttime.pdf</ext-link>. <access-date>Accessed November 2, 2011</access-date>.</citation>
</ref>
<ref id="bibr30-0148607112444608">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Han</surname><given-names>YY</given-names></name>
<name><surname>Carcillo</surname><given-names>JA</given-names></name>
<name><surname>Venkataraman</surname><given-names>ST</given-names></name><etal/>
</person-group>. <article-title>Unexpected increased mortality after implementation of a commercially sold computerized physician order entry system</article-title>. <source>Pediatrics</source>. <year>2005</year>;<volume>116</volume>:<fpage>1506</fpage>-<lpage>1512</lpage>.</citation>
</ref>
<ref id="bibr31-0148607112444608">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Rosse</surname><given-names>F</given-names></name>
<name><surname>Maat</surname><given-names>B</given-names></name>
<name><surname>Rademaker</surname><given-names>CM</given-names></name>
<name><surname>van Vught</surname><given-names>AJ</given-names></name>
<name><surname>Egberts</surname><given-names>AC</given-names></name>
<name><surname>Bollen</surname><given-names>CW.</given-names></name>
</person-group> <article-title>The effect of computerized physician order entry on medication prescription errors and clinical outcome in pediatric and intensive care: a systematic review</article-title>. <source>Pediatrics</source>. <year>2009</year>;<volume>123</volume>:<fpage>1184</fpage>-<lpage>1190</lpage>.</citation>
</ref>
<ref id="bibr32-0148607112444608">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Doormaal</surname><given-names>JE</given-names></name>
<name><surname>van</surname><given-names>den</given-names></name>
<name><surname>Bemt</surname><given-names>PM</given-names></name>
<name><surname>Zaal</surname><given-names>RJ</given-names></name><etal/>
</person-group>. <article-title>The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study</article-title>. <source>J Am Med Inform Assoc</source>. <year>2009</year>;<volume>16</volume>:<fpage>816</fpage>-<lpage>825</lpage>.</citation>
</ref>
<ref id="bibr33-0148607112444608">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kazemi</surname><given-names>A</given-names></name>
<name><surname>Ellenius</surname><given-names>J</given-names></name>
<name><surname>Pourasghar</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>The effect of computerized physician order entry and decision support system in medication errors in the neonatal ward: experiences from an Iranian teaching hospital</article-title>. <source>J Med Syst</source>. <year>2011</year>;<volume>35</volume>:<fpage>25</fpage>-<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr34-0148607112444608">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Branco</surname><given-names>RG</given-names></name>
<name><surname>Xavier</surname><given-names>L</given-names></name>
<name><surname>Garcia</surname><given-names>PC</given-names></name><etal/>
</person-group>. <article-title>Prospective operationalization and feasibility of a glycemic control protocol in critically ill children</article-title>. <source>Pediatr Crit Care Med</source>. <year>2011</year>;<volume>12</volume>:<fpage>265</fpage>-<lpage>270</lpage>.</citation>
</ref>
<ref id="bibr35-0148607112444608">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Faraon-Pogaceanu</surname><given-names>C</given-names></name>
<name><surname>Banasiak</surname><given-names>KJ</given-names></name>
<name><surname>Hirshberg</surname><given-names>EL</given-names></name>
<name><surname>Faustino</surname><given-names>EV.</given-names></name>
</person-group> <article-title>Comparison of the effectiveness and safety of two insulin infusion protocols in the management of hyperglycemia in critically ill children</article-title>. <source>Pediatr Crit Care Med</source>. <year>2010</year>;<volume>11</volume>:<fpage>741</fpage>-<lpage>749</lpage>.</citation>
</ref>
<ref id="bibr36-0148607112444608">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Verhoeven</surname><given-names>JJ</given-names></name>
<name><surname>Brand</surname><given-names>JB</given-names></name>
<name><surname>van de Polder</surname><given-names>MM</given-names></name>
<name><surname>Joosten</surname><given-names>KF.</given-names></name>
</person-group> <article-title>Management of hyperglycemia in the pediatric intensive care unit: implementation of a glucose control protocol</article-title>. <source>Pediatr Crit Care Med</source>. <year>2009</year>;<volume>10</volume>:<fpage>648</fpage>-<lpage>652</lpage>.</citation>
</ref>
<ref id="bibr37-0148607112444608">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dossett</surname><given-names>LA</given-names></name>
<name><surname>Collier</surname><given-names>B</given-names></name>
<name><surname>Donahue</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Intensive insulin therapy in practice: can we do it?</article-title> <source>JPEN J Parenter Enteral Nutr</source>. <year>2009</year>;<volume>33</volume>:<fpage>14</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr38-0148607112444608">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dortch</surname><given-names>MJ</given-names></name>
<name><surname>Mowery</surname><given-names>NT</given-names></name>
<name><surname>Ozdas</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2008</year>;<volume>32</volume>:<fpage>18</fpage>-<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr39-0148607112444608">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vogelzang</surname><given-names>M</given-names></name>
<name><surname>Loef</surname><given-names>BG</given-names></name>
<name><surname>Regtien</surname><given-names>JG</given-names></name><etal/>
</person-group>. <article-title>Computer-assisted glucose control in critically ill patients</article-title>. <source>Intensive Care Med</source>. <year>2008</year>;<volume>34</volume>:<fpage>1421</fpage>-<lpage>1427</lpage>.</citation>
</ref>
<ref id="bibr40-0148607112444608">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Preissig</surname><given-names>CM</given-names></name>
<name><surname>Hansen</surname><given-names>I</given-names></name>
<name><surname>Roerig</surname><given-names>PL</given-names></name>
<name><surname>Rigby</surname><given-names>MR.</given-names></name>
</person-group> <article-title>A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit</article-title>. <source>Pediatr Crit Care Med</source>. <year>2008</year>;<volume>9</volume>:<fpage>581</fpage>-<lpage>588</lpage>.</citation>
</ref>
<ref id="bibr41-0148607112444608">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boord</surname><given-names>JB</given-names></name>
<name><surname>Sharifi</surname><given-names>M</given-names></name>
<name><surname>Greevy</surname><given-names>RA</given-names></name><etal/>
</person-group>. <article-title>Computer-based insulin infusion protocol improves glycemia control over manual protocol</article-title>. <source>J Am Med Inform Assoc</source>. <year>2007</year>;<volume>14</volume>:<fpage>278</fpage>-<lpage>287</lpage>.</citation>
</ref>
<ref id="bibr42-0148607112444608">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manzoni</surname><given-names>P</given-names></name>
<name><surname>Castagnola</surname><given-names>E</given-names></name>
<name><surname>Mostert</surname><given-names>M</given-names></name>
<name><surname>Sala</surname><given-names>U</given-names></name>
<name><surname>Galletto</surname><given-names>P</given-names></name>
<name><surname>Gomirato</surname><given-names>G.</given-names></name>
</person-group> <article-title>Hyperglycaemia as a possible marker of invasive fungal infection in preterm neonates</article-title>. <source>Acta Paediatr</source>. <year>2006</year>;<volume>95</volume>:<fpage>486</fpage>-<lpage>493</lpage>.</citation>
</ref>
<ref id="bibr43-0148607112444608">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caldwell</surname><given-names>NA</given-names></name>
<name><surname>Power</surname><given-names>B.</given-names></name>
</person-group> <article-title>The pros and cons of electronic prescribing for children</article-title>. <source>Arch Dis Child</source>. <year>2012</year>;<volume>97</volume>:<fpage>124</fpage>-<lpage>128</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>